Ongoing

2

105

Europe

Cannabinor,

Pharmos Corp.

Cannabinor is as an analgesic and anti-inflammatory agent. By its nature, it has been designed to be more active at the CB2 peripheral receptors and have less activity at the central CB1 receptors. Thus, by design, cannabinor is expected to have less psychotropic effect than natural cannabinoids, such as those found in cannabis (including THC).